Timp2 loss-of-function mutation and TIMP2 treatment in a murine model of NSCLC: Modulation of immunosuppression and oncogenic signaling.

Transl Oncol · 2025 · PMC11846589 · PMID 39904284

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

In addition, these results demonstrate a clear trend towards decreased expression of Fibronectin 1, Myc, and Twist in the tumor-free and rTIMP2-treated wt mice.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.